Senti Biosciences Holdings Shareholder Meeting
Senti Biosciences held its reconvened 2026 Annual Meeting of Stockholders where shareholders elected three Class I directors and ratified KPMG LLP as the independent auditor. Crucially, stockholders approved the Merger Agreement with ST NewCo Limited and authorized a reverse stock split at a ratio between 1-for-20 and 1-for-50.